Clinical Report: CACUL1 Enhances Tumor Cell Growth and Immune Suppression
Overview
CACUL1 overexpression is linked to poor prognosis in hepatocellular carcinoma (HCC), promoting tumor cell proliferation and immune evasion. Its role in M2 macrophage polarization through Notch1 suppression is noted.
Background
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality, with limited treatment options and poor survival rates. Understanding the molecular mechanisms driving HCC progression is crucial for developing targeted therapies. The cullin-family E3 ubiquitin ligases, particularly CACUL1, have emerged as significant players in oncogenesis, yet their specific roles in HCC remain underexplored.
Data Highlights
Finding
Value
CACUL1 overexpression in HCC
P < 0.001
Prognostic significance in 16 tumor types
log-rank P < 0.01
Independent predictor of poor HCC prognosis
P < 0.05
Inhibition of HCC cell proliferation and migration
Yes
PI3K/AKT pathway enrichment
Yes
Key Findings
CACUL1 is overexpressed in HCC and gastric cancer.
High CACUL1 expression correlates with advanced clinicopathological features.
CACUL1 knockout reduces HCC cell proliferation and migration.
CACUL1 promotes M2 macrophage polarization via Notch1 suppression.
CACUL1 expression is a candidate prognostic biomarker in HCC.
Clinical Implications
Monitoring CACUL1 levels could serve as a prognostic tool for assessing disease progression.
Conclusion
Further investigation into CACUL1's role in HCC is warranted.
